Synthetic RORγt Agonists Enhance Protective Immunity

ACS Chemical Biology
Mi Ra ChangPatrick R Griffin

Abstract

The T cell specific RORγ isoform RORγt has been shown to be the key lineage-defining transcription factor to initiate the differentiation program of TH17 and TC17 cells, cells that have demonstrated antitumor efficacy. RORγt controls gene networks that enhance immunity including increased IL17 production and decreased immune suppression. Both synthetic and putative endogenous agonists of RORγt have been shown to increase the basal activity of RORγt enhancing TH17 cell proliferation. Here, we show that activation of RORγt using synthetic agonists drives proliferation of TH17 cells while decreasing levels of the immune checkpoint protein PD-1, a mechanism that should enhance antitumor immunity while blunting tumor associated adaptive immune resistance. Interestingly, putative endogenous agonists drive proliferation of TH17 cells but do not repress PD-1. These findings suggest that synthetic agonists of RORγt should activate TC17/TH17 cells (with concomitant reduction in the Tregs population), repress PD-1, and produce IL17 in situ (a factor associated with good prognosis in cancer). Enhanced immunity and blockage of immune checkpoints has transformed cancer treatment; thus such a molecule would provide a unique approach for the t...Continue Reading

References

Jul 9, 2004·The Journal of Immunology : Official Journal of the American Association of Immunologists·Jens M ChemnitzJames L Riley
May 17, 2007·Expert Opinion on Therapeutic Targets·Zhaofeng HuangZuoming Sun
Nov 18, 2009·The Journal of Immunology : Official Journal of the American Association of Immunologists·Hung-Rong YenCharles G Drake
Mar 26, 2010·Nature Reviews. Immunology·Weiping Zou, Nicholas P Restifo
Feb 2, 2012·ACS Chemical Biology·Naresh KumarPatrick R Griffin
Apr 12, 2012·The Journal of Immunology : Official Journal of the American Association of Immunologists·Margarite L TarrioAndrew H Lichtman
Jun 5, 2012·The New England Journal of Medicine·Suzanne L TopalianMario Sznol
Jun 5, 2012·The New England Journal of Medicine·Julie R BrahmerJon M Wigginton
Jun 14, 2012·Journal of the American Society for Mass Spectrometry·Bruce D PascalPatrick R Griffin
Jun 4, 2013·The New England Journal of Medicine·Omid HamidAntoni Ribas
Jun 4, 2013·The New England Journal of Medicine·Jedd D WolchokMario Sznol
Feb 12, 2014·The Journal of Immunology : Official Journal of the American Association of Immunologists·Jill SkepnerJianfei Yang
Mar 5, 2014·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Suzanne L TopalianF Stephen Hodi
Nov 28, 2014·Nature·Matthew M GubinRobert D Schreiber
Feb 5, 2015·Cell Metabolism·Fabio R SantoriDan R Littman
Mar 11, 2015·Nature·Christina Twyman-Saint VictorAndy J Minn
Mar 31, 2015·ACS Medicinal Chemistry Letters·Olivier RenéHarvey Wong
Jun 13, 2015·Nature Communications·David P MarcianoPatrick R Griffin
Dec 8, 2015·Nature Communications·Marcel ScheepstraLuc Brunsveld

❮ Previous
Next ❯

Citations

Aug 21, 2016·Bioorganic & Medicinal Chemistry Letters·Patrick CyrJames J Crawford
Nov 24, 2016·ChemMedChem·Christelle DoebelinTheodore M Kamenecka
Jun 8, 2019·ELife·Timothy S StrutzenbergPatrick R Griffin
Aug 15, 2020·Frontiers in Pharmacology·Lucia ToporovaPatrick Balaguer
Mar 7, 2020·Scientific Reports·Lucas Leite CunhaLaura Sterian Ward
Oct 30, 2020·Natural Product Reports·Angela LadurnerVerena M Dirsch
Mar 2, 2019·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Devalingam MahalingamH Jeffrey Wilkins
Dec 5, 2020·European Journal of Medicinal Chemistry·Yuehan XiaYonghui Wang
Jan 11, 2021·Bioorganic & Medicinal Chemistry Letters·Zheming RuanLalgudi S Harikrishnan
May 10, 2020·Trends in Immunology·Sabina Y van der ZandenHuib Ovaa
Jul 25, 2021·European Journal of Medicinal Chemistry·Ruomeng QiuQiong Xie
Jan 26, 2021·ACS Medicinal Chemistry Letters·Christian HarckenRobert O Hughes

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cell Checkpoints & Regulators

Cell cycle checkpoints are a series of complex checkpoint mechanisms that detect DNA abnormalities and ensure that DNA replication and repair are complete before cell division. They are primarily regulated by cyclins, cyclin-dependent kinases, and the anaphase-promoting complex/cyclosome. Here is the latest research.